Approved IV drug reduces lupus symptoms, clinical trial finds
An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms ...
Mar 10, 2026
0
0









